Actively Recruiting
Dexmedetomidine Wound Infiltration in Cesarean Section
Led by Attikon Hospital · Updated on 2025-03-19
100
Participants Needed
1
Research Sites
378 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The effects of four different wound infiltration protocols in cesarean section will be investigated on parturient' pain intensity, PCA morphine consumption given, side effects and parturient' overall satisfaction. One group will receive for wound infiltration dexmedetomidine, the second ropivacaine, the third dexmedetomidine combined with ropivacaine, while the last one will receive normal saline (placebo group).
CONDITIONS
Official Title
Dexmedetomidine Wound Infiltration in Cesarean Section
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women at more than 37 weeks gestation
- American Society of Anesthesiologists (ASA) physical status I or II
- Body mass index (BMI) less than 35
You will not qualify if you...
- Patient refusal to participate
- History of epilepsy
- Gastroesophageal reflux disease (GERD)
- Morbid obesity
- Allergy to study drugs
- ASA physical status class higher than II
- Presence of atrioventricular block
- Severe systemic disease
- Multiple pregnancy
- High-risk pregnancy
- Contraindications to epidural anesthesia
- History of recreational drug or alcohol use
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Paraskevi K Matsota
Athens, Other, Greece, 13231
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here